Champions Oncology Q1 revenue record $11.3M, up 18% YoY; non-GAAP op income $422k

CHAMPIONS ONCOLOGY, INC.

2022-Q1 EPS reported -$0.01 revenue$11,253,000

Record quarterly revenue of $11.3M, +17.9% YoY, driven by larger studies and platform expansion.
GAAP operating loss of $175k; non-GAAP operating income of $422k, excluding $280k stock comp and $317k D&A.
Gross margin improved to 52.0% from 44.1% as more lab work was performed internally.
Cash position $4.0M with no debt; net cash from operations $216k in the quarter.
Validated 6 therapeutic discovery targets; SaaS platform Lumin Bioinformatics adding new users.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.